TOPIC

Made in China 2025

Made in China 2025
Launched by Premier Li Keqiang in 2015, the “Made in China 2025" strategy aims to guide the country’s industrial modernisation, including the substitution of foreign technology with innovation developed on the mainland.
Biomedicine: Industry Trends

China’s pharmaceutical industry transforms into a global innovation powerhouse

The China Pharmaceutical Innovation and Invention Index, a new gauge, highlights top drug makers on the mainland for the first time.

Can rising lithium costs save China’s energy storage firms from a price war?

Chinese biotech Scizeng’s global licensing deal to yield up to US$1.44 billion

Yarrow Bioscience gets exclusive global rights for the GenSci098 therapy to treat thyroid eye disease and Graves’ disease.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement